title: [New information about fumaric acid esters (Fumaderm): results of a workshop of experts].
authors: Ulrich
authors: U
authors: Mrowietz
authors: A
authors: A
authors: Adamczyk
authors: M
authors: M
authors: Augustin
authors: W H
authors: WH
authors: Boehncke
authors: B
authors: B
authors: Bonnekoh
authors: T
authors: T
authors: Gambichler
authors: U
authors: U
authors: Hengge
authors: U
authors: U
authors: Lippert
authors: R J
authors: RJ
authors: Ludwig
authors: T
authors: T
authors: Luger
authors: H F
authors: HF
authors: Merk
authors: J
authors: J
authors: Norgauer
authors: S
authors: S
authors: Philipp
authors: K
authors: K
authors: Reich
authors: M
authors: M
authors: Röcken
authors: M
authors: M
authors: Rostami-Yazdi
authors: M P
authors: MP
authors: Schön
authors: N
authors: N
authors: Scola
authors: M
authors: M
authors: Sticherling
authors: D
authors: D
authors: Thaci
authors: A
authors: A
authors: Viehweg
authors: K
authors: K
authors: Wallbrecht
authors: G
authors: G
authors: Wozel
authors: C C
authors: CC
authors: Zouboulis
authors: M
authors: M
authors: Neureither
mesh_terms: D000284:Administration, Oral; D000506:Alopecia Areata / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000523:psychology; D001682:Biological Availability; D002986:Clinical Trials as Topic; D015897:Comorbidity; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000009:adverse effects* / Q000493:pharmacokinetics; D000069462:Dimethyl Fumarate; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004493:Education; D000068800:Etanercept; D005500:Follow-Up Studies; D005650:Fumarates / Q000008:administration & dosage* / Q000009:adverse effects* / Q000493:pharmacokinetics; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage / Q000009:adverse effects; D008657:Metabolic Clearance Rate / Q000502:physiology; D011701:PUVA Therapy / Q000379:methods; D010865:Pilot Projects; D011446:Prospective Studies; D011565:Psoriasis / Q000188:drug therapy* / Q000453:epidemiology / Q000523:psychology; D011788:Quality of Life; D018124:Receptors, Tumor Necrosis Factor / Q000008:administration & dosage; D012042:Registries; D012803:Sick Role
chemical_list: D003879:Dermatologic Agents; D005650:Fumarates; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000069462:Dimethyl Fumarate; D000068800:Etanercept